CR8876A - 1,1,2,2-TETRA (HETERO) ARILETANOS 1,1,2-TRI (HETERO) -ARIL-2-HETEROCICLOETANOS AS INHIBITORS OF POTASSIUM CHANNELS - Google Patents

1,1,2,2-TETRA (HETERO) ARILETANOS 1,1,2-TRI (HETERO) -ARIL-2-HETEROCICLOETANOS AS INHIBITORS OF POTASSIUM CHANNELS

Info

Publication number
CR8876A
CR8876A CR8876A CR8876A CR8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A CR 8876 A CR8876 A CR 8876A
Authority
CR
Costa Rica
Prior art keywords
hetero
inhibitors
heterocicloetanos
ariletanos
aril
Prior art date
Application number
CR8876A
Other languages
Spanish (es)
Inventor
T Bilodeau Mark
Wu Zhicai
Hartnett John
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CR8876A publication Critical patent/CR8876A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a compuestos que tienen la estructura que se muestra, utiles como inhibidores del canal de potasio para tratar arritmias cardiacas y afecciones similares.The present invention relates to compounds having the structure shown, useful as potassium channel inhibitors for treating cardiac arrhythmias and similar conditions.

CR8876A 2004-07-29 2007-01-25 1,1,2,2-TETRA (HETERO) ARILETANOS 1,1,2-TRI (HETERO) -ARIL-2-HETEROCICLOETANOS AS INHIBITORS OF POTASSIUM CHANNELS CR8876A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
CR8876A true CR8876A (en) 2007-08-28

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8876A CR8876A (en) 2004-07-29 2007-01-25 1,1,2,2-TETRA (HETERO) ARILETANOS 1,1,2-TRI (HETERO) -ARIL-2-HETEROCICLOETANOS AS INHIBITORS OF POTASSIUM CHANNELS

Country Status (15)

Country Link
KR (1) KR20070043985A (en)
AR (1) AR049847A1 (en)
BR (1) BRPI0513793A (en)
CR (1) CR8876A (en)
EC (1) ECSP077208A (en)
IL (1) IL180846A0 (en)
MA (1) MA28980B1 (en)
MX (1) MX2007001188A (en)
NO (1) NO20071107L (en)
PE (1) PE20060382A1 (en)
RU (1) RU2344134C2 (en)
TW (1) TW200607493A (en)
UA (1) UA88018C2 (en)
WO (1) WO2006028590A1 (en)
ZA (1) ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012520829A (en) * 2009-03-18 2012-09-10 メディキュア・インターナショナル・インコーポレーテッド Tirofiban transdermal pharmaceutical formulation and administration
TWI571470B (en) 2012-06-11 2017-02-21 必治妥美雅史谷比公司 Phosphoramidic acid prodrugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1911740B1 (en) * 2002-01-04 2013-02-27 NeuroSearch A/S Potassium channel modulators

Also Published As

Publication number Publication date
KR20070043985A (en) 2007-04-26
MA28980B1 (en) 2007-11-01
MX2007001188A (en) 2007-03-21
IL180846A0 (en) 2007-06-03
ECSP077208A (en) 2007-02-28
RU2007107408A (en) 2008-09-10
RU2344134C2 (en) 2009-01-20
UA88018C2 (en) 2009-09-10
WO2006028590A1 (en) 2006-03-16
ZA200700477B (en) 2009-08-26
NO20071107L (en) 2007-04-19
TW200607493A (en) 2006-03-01
BRPI0513793A (en) 2008-05-13
AR049847A1 (en) 2006-09-06
PE20060382A1 (en) 2006-05-15

Similar Documents

Publication Publication Date Title
EA201270378A1 (en) QUINAZOLINS AS AN INHIBITORS OF POTASSIUM CHANNELS
ECSP088676A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
PA8667201A1 (en) NEW PHARMACEUTICAL COMPOUNDS
ATE510822T1 (en) POTASSIUM CHANNEL INHIBITORS
DOP2010000225A (en) INSECTICIDED ARILPIRROLINAS
ECSP088210A (en) SUBSTITUTED BENCIMIDAZOLS AND PREPARATION METHODS
JO2853B1 (en) Sulfonamides as TRPM8 Modulators
CU20120071A7 (en) USEFUL N1-PIRAZOLOESPIROCETONE DERIVATIVES AS ACETIL-CoA CARBOXYLASE INHIBITORS
TR201901649T4 (en) Compositions and methods for controlling nematodes and soil borne diseases.
GT200500102A (en) ORTOSUSTITUTED ARIL-O-HETEROARILAMIDE COMPOUNDS
BRPI0519521A2 (en) thiene pyridine derivatives as gaba-b allosteric enhancers
DOP2005000025A (en) HETEROARIL- AND FENILSULFAMOIL SUBSTITUTED COMPOUNDS
BRPI0508594A (en) ion channel modulators
BRPI0508522A (en) ion channel modulators
CR8111A (en) PIRROL REPLACED DERIVATIVES
CR11164A (en) TIRE INCLUDING SEGMENTED BEARING BANDS
ATE417849T1 (en) PYRAZOLOA4,3-DÜPYRIMIDINE
EA201170344A1 (en) AZAINDOL IAP INHIBITORS
UY31273A1 (en) PHENILENDIAMINS REPLACED AS INHIBITORS OF INTERACTION BETWEEN MDM2 AND P53
ATE549024T1 (en) QUINAZOLINE POTASSIUM CHANNEL INHIBITORS
BRPI0412636A (en) Substituted imidazopyrimidines for cancer prevention and treatment
ECSP088476A (en) COMBINATION OF FUNGICIDE ACTIVE PRODUCTS
UY27772A1 (en) TRIARILOXIARILOXIPIRIMIDIN-2,4,6- METALOPROTEINASE TRIONA INHIBITORS.
BRPI0508550A (en) ion channel modulators
CR8876A (en) 1,1,2,2-TETRA (HETERO) ARILETANOS 1,1,2-TRI (HETERO) -ARIL-2-HETEROCICLOETANOS AS INHIBITORS OF POTASSIUM CHANNELS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)